Portfolio Advancing Portfolio Screening Program RFP Year2017 Awarded Amount $99,986 DiseaseTuberculosis InterventionDrug Development Stage Hit Identification Collaboration Partners Astellas Pharma Inc., The Global Alliance for TB Drug Development